About this trial
Severe periodontitis is widespread and begins with reversible gingivitis, driven by poor oral hygiene and a dysbiotic microbiome. Daily toothbrushing is the simplest prevention, but patients still leave plaque. Electric brushes remove more plaque and reduce gingivitis better than manual ones, and users show better periodontal status. App-connected smart brushes and apps aim to improve adherence. Trials increased plaque reduction and brushing time versus manual brushing, but app layers have not clearly beaten standard power brushes, and microbiological outcomes are rarely reported. Xiaomi's AI-based sonic T501 adds pressure sensing, personalised coaching and coverage tracking, whereas the T302 is a simpler non-connected sonic brush. Streptococcus sanguinis is a health-associated early coloniser; its qPCR-measured relative abundance marks a healthy supragingival profile. It is still unclear whether AI guidance adds extra benefit beyond a standard electric brush in adult gingivitis.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Participants should be systemically healthy
18 years old, with the presence of ≥ 20 teeth
Diagnosed with generalized plaque-induced gingivitis having >30% bleeding sites, with probing depths ≤3 mm and intact periodontium
Participants with at least secondary school education, who are able to read and understand basic English to follow the app-based toothbrush instructions
Disqualifiers
Participants who using antibiotics or anti-inflammatory medication throughout the investigation or during the previous 3 months prior to the study.
Drug-induced gingival enlargement (phenytoin, cyclosporine, calciumchannel blockers).
Individuals with periodontitis and healthy periodontium.
Mouth breathers .
Trial design
Parallel
Treatments tested in this trial
AI toothbrush
DeviceSmart toothbrush supported with AI applications to improve toothbrushing experience
Manual toothbrush
DeviceManual toothbrush used as a gold standard control
Electric toothbrush
DeviceElectric toothbrush as a second control group
Treatment groups
Trial outcomes
Primary outcomes
Plaque index
Turesky-modified Quigley-Hein Plaque Index will be quantified on a scale between 0 to 5: 0 No plaque 1. Isolated areas of plaque at the cervical margin of the tooth. 2. A thin continuous band of plaque (up to 1 mm) at cervical margin of tooth. 3. A band of plaque wider than 1 mm but covering less than one- third of the crown of the tooth. 4. Plaque covering at least one-third but less than two-thirds of the crown of the tooth. 5. plaque covering two-thirds or more of the crown of the tooth.
Secondary outcomes
Modified sulcular bleeding index
Bleeding after probing gingival sulcus will be scored as follows: Score 0: No bleeding. Score 1: Isolated spots bleeding. Score 2: Blood forms a confluent red line or margin. Score 3: Heavy or profuse bleeding
Compliance to oral hygiene instructions and level of satisfaction
Degree of compliance and patient-reported outcome about satisfaction level after using different types of toothbrushes using a questionnaire
Microbiological analysis
Relative abundance of Streptococcus Sanguinis in supragingival plaque samples will be measured using PCR technique.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: